RxDoctor Payments Data

Jon Sides, MD

Family Medicine · Burlington, KSNPI 1912901885

Payments from drug & device makers

$4,642in general payments, 2019–2025

Across 295 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$871
  • Novo Nordisk$680
  • Otsuka America Pharmaceutical, Inc.$359
  • Lilly USA, LLC$302
  • Amgen$209
  • Sunovion Pharmaceuticals Inc.$200
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$4,628100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,642 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$9,709
Medicare patients
120
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban92$68,806
OzempicSemaglutide47$63,984
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$33,098
JanuviaSitagliptin Phosphate26$30,807
MyrbetriqMirabegron44$29,853
XareltoRivaroxaban35$23,602
Tresiba Flextouch U-100Insulin Degludec14$16,834
MovantikNaloxegol Oxalate24$10,394
TradjentaLinagliptin12$6,809
Pantoprazole Sodium496$5,892
Advair HfaFluticasone Propion/Salmeterol15$5,694
Novolog FlexpenInsulin Aspart21$5,292
Breo ElliptaFluticasone/Vilanterol12$5,104
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$5,090
SymbicortBudesonide/Formoterol Fumarate14$4,439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$140$68,80692 claims
Novo NordiskOzempic$680$63,98447 claims
GSKTrelegy Ellipta, Breo Ellipta$14$38,20256 claims
MerckJanuvia$76$30,80726 claims
Astellas Pharma US IncMyrbetriq$20$29,85344 claims
Johnson & JohnsonXarelto$160$23,60235 claims
Boehringer IngelheimTradjenta$139$6,80912 claims
AstraZenecaSymbicort$56$4,43914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Burlington

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →